CAS 1821387-73-8

Fórmula: C17H13F3N4O2

InChI: InChI=1S/C17H13F3N4O2/c1-21-14-7-6-13(24(25)26)8-16(14)23-9-15(22-10-23)11-2-4-12(5-3-11)17(18,19)20/h2-10,21H,1H3

Chave InChI: LITXVDAFEYLWQE-UHFFFAOYSA-N

SMILES: CNC1=C(C=C(C=C1)[N+](=O)[O-])N2C=C(N=C2)C3=CC=C(C=C3)C(F)(F)F

CU-T12-9

CAS: 1821387-73-8

CU-T12-9 is a potent TLR1/2 agonist(EC50 of 52.9 nM in HEK-Blue hTLR2 SEAP assay).

Fórmula: C₁₇H₁₃F₃N₄O₂

Pureza: 99.84%

Cor e Forma: Solid

Peso molecular: 362.31

Ref: TM-T15017

CU-T12-9

CAS: 1821387-73-8

CU-T12-9

Fórmula: C₁₇H₁₃F₃N₄O₂

Pureza: ≥98%

Peso molecular: 362.31

Ref: 54-BUP08452

CU-T12-9

CAS: 1821387-73-8

Fórmula: C₁₇H₁₃F₃N₄O₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 362.3059

Ref: IN-DA00ATEE

CU-T12-9

CAS: 1821387-73-8

N-Methyl-4-nitro-2-(4-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)aniline

Fórmula: C₁₇H₁₃F₃N₄O₂

Pureza: 98%

Peso molecular: 362.31

Ref: IN-DG01184592

CU-T12-9

Produto Controlado

CAS: 1821387-73-8

Fórmula: C₁₇H₁₃F₃N₄O₂

Cor e Forma: Neat

Peso molecular: 362.306

Ref: TR-C852000

CU-T12-9

CAS: 1821387-73-8

CU-T12-9 is a molecule that belongs to the group of toll-like receptor (TLR) agonists. It activates TLRs and has potent inhibitory activity against IL-10, TNF-α, and other inflammatory cytokines. CU-T12-9 also prevents the growth of cancer cells by inhibiting the production of tumor necrosis factor alpha (TNFα). CU-T12-9 is highly specific for human macrophages, which makes it an excellent candidate for drug development in the treatment of inflammatory conditions such as cancer. This chemical has been shown to activate TLRs on human macrophages and reduce the production of inflammatory cytokines such as IL-10, TNFα, and other inflammatory cytokines.

Fórmula: C₁₇H₁₃F₃N₄O₂

Pureza: Min. 95%

Peso molecular: 362.31 g/mol

Ref: 3D-WXC38773